RMFEX
Price
$58.54
Change
-$0.03 (-0.05%)
Updated
Sep 20 closing price
VIVAX
Price
$67.77
Change
-$0.06 (-0.09%)
Updated
Sep 20 closing price
Ad is loading...

RMFEX vs VIVAX

Header iconRMFEX vs VIVAX Comparison
Open Charts RMFEX vs VIVAXBanner chart's image
American Funds American Mutual R4
Price$58.54
Change-$0.03 (-0.05%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$67.77
Change-$0.06 (-0.09%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RMFEX vs VIVAX Comparison Chart
Loading...
VS
RMFEX vs. VIVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFEX is a Buy and VIVAX is a Buy.

FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 183B vs. RMFEX (105B). VIVAX pays higher dividends than RMFEX: VIVAX (2.25) vs RMFEX (1.95). RMFEX was incepted earlier than VIVAX: RMFEX (22 years) vs VIVAX (32 years). RMFEX is a more actively managed with annual turnover of: 25.00 vs. VIVAX (10.00). RMFEX has a lower initial minimum investment than VIVAX: RMFEX (250) vs VIVAX (3000). VIVAX (23.98) and RMFEX (23.63) have marching annual gain over last year. VIVAX return over 5 years is better than : 55.44 vs. RMFEX (51.72).
RMFEXVIVAXRMFEX / VIVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years32 years-
Gain YTD16.65316.261102%
Front LoadN/AN/A-
Min. Initial Investment25030008%
Min. Initial Investment IRAN/AN/A-
Net Assets105B183B57%
Annual Yield % from dividends1.952.2587%
Returns for 1 year23.6323.9899%
Returns for 3 years24.5828.2887%
Returns for 5 years51.7255.4493%
Returns for 10 years79.18113.9569%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VNOM45.660.21
+0.46%
Viper Energy
AUGX2.33N/A
N/A
Augmedix
TERN10.02-0.02
-0.20%
Terns Pharmaceuticals
STLD119.83-0.26
-0.22%
Steel Dynamics
TNXP0.15N/A
-1.67%
Tonix Pharmaceuticals Holding Corp.